tetrabenazine
Commercial- Indications
- Chorea in Huntington's disease
Company intelligence / Profile preview
Prestwick Pharmaceuticals
Washington, DC, United Statesprestwickpharma.com ↗
- Ownership
- Private
- Employees
- ~29
- Development stage
- Commercial
01
Overview
Prestwick Pharmaceuticals developed CNS drugs targeting unmet needs. Its lead product was tetrabenazine/Xenazine®—a VMAT2 inhibitor approved in Europe and later the U.S. for chorea associated with Huntington's disease. The company also had late-stage assets targeting advanced Parkinson's and early pipeline programs addressing additional CNS conditions such as schizophrenia and sleep apnea. The company was acquired by Biovail Corporation in September 2008.
- Therapeutic areas
- PulmonologyPsychiatryNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Ovation Pharmaceuticals—U.S. commercialization partner for Xenazine/tetrabenazine prior to acquisition by Biovail
Beyond the preview
Go deeper on Prestwick Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prestwick Pharmaceuticals.